Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 7Acquired Immunodeficiency Syndrome 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Human Papillomavirus-Related Cervical Carcinoma 1High Grade Anal Canal Intraepithelial Neoplasia 1Hematologic Neoplasms 1HIV Infections 1

Interventions

Ritonavir 2Human Papillomavirus Recombinant Vaccine nonavalent 2dolutegravir 1Papillomavirus Vaccines 1Nucleosides 1Nevirapine 1Lopinavir 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1Emtricitabine 1Darunavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Acquired Immunodeficiency Syndrome × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT04982614 2025-08-24

HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini

Columbia University

Phase 4 Completed
1,403 enrolled

Acquired Immunodeficiency Syndrome, Papillomavirus Infections

NCT05266898 2025-04-18

AGO-Gard

Louisiana State University Health Sciences Center in New Orleans

Phase 4 Recruiting
250 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡